EC Ophthalmology

Review Article Volume 15 Issue 11 - 2024

Angle-Closure Glaucoma: An Insight

Anuradha Raj1* and Vinita Kumari2

1Professor, Department of Ophthalmology, All India Institute of Medical Sciences, Bathinda, Punjab, India
2Junior Resident, Department of Ophthalmology, All India Institute of Medical Sciences, Bathinda, Punjab, India

*Corresponding Author: Anuradha Raj, Professor, Department of Ophthalmology, All India Institute of Medical Sciences, Bathinda, Punjab, India.
Received: August 26, 2024; Published: October 29, 2024




Primary angle-closure glaucoma is a serious condition responsible for nearly half of all cases of glaucoma-related blindness globally. The risk is notably higher in women, older adults, and individuals with hyperopia, with the highest prevalence observed in Asia. Ongoing research is exploring the genetic mechanisms behind glaucoma inheritance. Diagnosis is primarily conducted through gonioscopy, often supplemented by anterior segment optical coherence tomography (AS-OCT) and ultrasound biomicroscopy (UBM). Initial treatment usually involves pressure-lowering eye drops. The peripheral iridotomy is frequently performed to alleviate pupillary block, while laser iridoplasty has shown effectiveness for other closure mechanisms like plateau iris syndrome. Phacoemulsification, with or without goniosynechialysis, is an emerging treatment for both cataracts and clear lenses, with its long-term efficacy in early-stage angle closure under investigation. Cyclophotocoagulation, sometimes combined with cataract surgery, is another treatment option. For more advanced cases, trabeculectomy remains a reliable therapeutic approach.

 Keywords: Angle-Closure Glaucoma; Pupillary Block; Laser Peripheral Iridotomy; Phacoemulsification; Plateau Iris; Primary Angle Closure

  1. Quigley HA., et al. “The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER”. Archives of Ophthalmology 12 (2001): 1819-1826.
  2. Resnikoff S., et al. “Global data on visual impairment in the year 2002”. Bulletin of the World Health Organization11 (2004): 844-851.
  3. Day AC., et al. “The prevalence of primary angle closure glaucoma in European derived populations: a systematic review”. British Journal of Ophthalmology9 (2012): 1162-1167.
  4. Tham YC., et al. “Global prevalence of glaucoma and projections of glaucoma burden through 2040”. Ophthalmology 11 (2014): 2081-2090.
  5. Li H., et al. “Dynamic analysis of light-dark changes of the anterior chamber angle with anterior segment OCT”. Investigative Ophthalmology and Visual Science 9 (2007): 4116-4122.
  6. Kyari F., et al. “Epidemiology of glaucoma in Sub-Saharan Africa: prevalence, incidence and risk factors”. Middle East African Journal of Ophthalmology 2 (2013): 111-125.
  7. Heys JJ., et al. “Modeling passive mechanical interaction between aqueous humor and iris”. Journal of Biomechanical Engineering 6 (2001): 540-547.
  8. Wyatt H., et al. “Behavior of an iris model and the pupil block hypothesis”. British Journal of Ophthalmology 3 (1970): 177-185.
  9. Tarongoy P., et al. “Angle-closure glaucoma: the role of the lens in the pathogenesis, prevention, and treatment”. Survey of Ophthalmology 2 (2009): 211-225.
  10. Quigley HA., et al. “Possible mechanisms of primary angle-closure and malignant glaucoma”. Journal of Glaucoma 2 (2003): 167-180.
  11. Lai J., et al. “Management of primary angle-closure glaucoma”. Asia-Pacific Journal of Ophthalmology (Phila) 1 (2016): 59-62.
  12. Tarongoy P., et al. “Angle-closure glaucoma: the role of the lens in the pathogenesis, prevention, and treatment”. Survey of Ophthalmology 2 (2009): 211-225.
  13. Pavlin CJ., et al. “Ultrasound biomicroscopy in plateau iris syndrome”. American Journal of Ophthalmology 4 (1992): 390-395.
  14. Wright C., et al. “Primary angle-closure glaucoma: an update”. Acta Ophthalmologica 3 (2016): 217-225.
  15. Leighton DA., et al. “Survey of the first-degree relatives of glaucoma patients”. Transactions of the Ophthalmological Societies of the United Kingdom 1 (1976): 28-32.
  16. Wolfs RC., et al. “Risk of acute angle-closure glaucoma after diagnostic mydriasis in nonselected subjects: The rotterdam study”. Investigative Ophthalmology and Visual Science 12 (1997): 2683-2687.
  17. Van Herick W., et al. “Estimation of width of angle of anterior chamber. Incidence and significance of the narrow angle”. American Journal of Ophthalmology 4 (1969): 626-629.
  18. Lowe RF., et al. “Aetiology of the anatomical basis for primary angle-closure glaucoma. Biometrical comparisons between normal eyes and eyes with primary angle-closure glaucoma”. British Journal of Ophthalmology 3 (1970): 161-169.
  19. Lavanya R., et al. “Screening for narrow angles in the Singapore population: Evaluation of new noncontact screening methods”. Ophthalmology10 (2008): 1720-1727.
  20. Kurita N., et al “Potential of the pentacam in screening for primary angle closure and primary angle closure suspect”. Journal of Glaucoma 7 (2009): 506-512.
  21. Suwan Y., et al. “Qualitative and quantitative evaluation of acute angle-closure mechanisms”. BMC Ophthalmology1 (2017): 246.
  22. Bean G., et al. “Commercially available prostaglandin analogs for the reduction of intraocular pressure: Similarities and differences”. Survey of Ophthalmology 1 (2008): S69-S84.
  23. Wolfs RC., et al. “Risk of acute angle-closure glaucoma after diagnostic mydriasis in nonselected subjects: The rotterdam study”. Investigative Ophthalmology and Visual Science 12 (1997): 2683-2687.
  24. Leighton DA., et al. “Survey of the first-degree relatives of glaucoma patients”. Transactions of the Ophthalmological Societies of the United Kingdom 1 (1976): 28-32.
  25. Subak-Sharpe I., et al. “Pharmacological and environmental factors in primary angle-closure glaucoma”. British Medical Bulletin 93 (2010): 125-143.
  26. Talluto D., et al. “Simultaneous angle closure in twins”. Journal of Glaucoma 1 (1998): 68-69.
  27. Li J., et al. “Drug-induced ocular disorders”. Drug Safety 2 (2008): 127-141.
  28. Palmberg P., et al. “Shedding light on gonioscopy”. Archives of Ophthalmology 10 (2007): 1417-1418.
  29. Barkana Y., et al. “Agreement between gonioscopy and ultrasound biomicroscopy in detecting iridotrabecular apposition”. Archives of Ophthalmology 10 (2007): 1331-1335.
  30. Foster PJ., et al. “Defining “occludable” angles in population surverys: drainage anger width, peripheral anterior synechiae, and glaucomatous optic neuropathy in east Asian people”. British Journal of Ophthalmology 4 (2004): 486-490.
  31. American Academy of Ophthalmology Glaucoma Panel. Preferred Practice Pattern Guidelines. Primary Angle Closure. San Francisco, CA: American Academy of Ophthalmology (2010).
  32. Garcia JP Jr., et al. “Anterior segment imaging: optical coherence tomography versus ultrasound biomicroscopy”. Ophthalmic Surgery, Lasers and Imaging Retina 6 (2008): 476-484.
  33. Vera V., et al. “Dysphotopsia after temporal versus superior laser peripheral iridotomy: A prospective randomized paired eye trial”. American Journal of Ophthalmology 5 (2014): 929-935.
  34. Friedman DS., et al. “Interventions for angle-closure glaucoma: an evidence-based update”. Ophthalmology 10 (2003): 1869-1878.
  35. lsagoff Z., et al. “Long-term clinical course of primary angle-closure glaucoma in an Asian population”. Ophthalmology12 (2000): 2300-2304.
  36. Ritch R., et al. “Argon laser peripheral iridoplasty for angle-closure glaucoma in siblings with Weill-Marchesani syndrome”. Journal of Glaucoma 4 (1992): 243-247.
  37. Lim AS., et al. “Laser iridoplasty in the treatment of severe acute angle closure glaucoma”. International Ophthalmology 1 (1993): 33-36.
  38. Sun X., et al. “Laser peripheral iridotomy with and without iridoplasty for primary angle-closure glaucoma: 1-year results of a randomized pilot study”. American Journal of Ophthalmology 1 (2010): 68-73.
  39. Liu CJ., et al. “Determinants of long-term intraocular pressure after phacoemulsification in primary angle-closure glaucoma”. Journal of Glaucoma 9 (2011): 566-570.
  40. Imaizumi M., et al. “Phacoemulsification and intraocular lens implantation for acute angle closure not treated or previously treated by laser iridotomy”. Journal of Cataract and Refractive Surgery 1 (2006): 85-90.
  41. Yoon JY., et al. “Cataract surgery in patients with acute primary angle-closure glaucoma”. Korean Journal of Ophthalmology 2 (2003): 122-126.
  42. Tanihara H., et al. “Surgical results and complications of goniosynechialysis”. Graefe's Archive for Clinical and Experimental Ophthalmology 4 (1992): 309-313.
  43. Harasymowycz PJ., et al. “Phacoemulsification and goniosynechialysis in the management of unresponsive primary angle closure”. Journal of Glaucoma3 (2005): 186-189.
  44. Kameda T., et al. “Long-term efficacy of goniosynechialysis combined with phacoemulsification for primary angle closure”. Graefe's Archive for Clinical and Experimental Ophthalmology 3 (2013): 825-830.
  45. Bloom P., et al. “A comparison between tube surgery, ND: YAG laser and diode laser cyclophotocoagulation in the management of refractory glaucoma”. Biomed Research International (2013): 371951.
  46. Bevin TH., et al. “Otago Glaucoma Surgery Outcome Study: long-term results of 841 trabeculectomies”. Clinical and Experimental Ophthalmology 8 (2008): 731-737.
  47. Lai JS., et al. “Diode laser transscleral cyclophotocoagulation in the treatment of chronic angle-closure glaucoma: a preliminary study”. Journal of Glaucoma 4 (2003): 360-364.
  48. Deokule SP., et al. “Long-term results of Molteno implant insertion in cases of chronic angle closure glaucoma”. Clinical and Experimental Ophthalmology 6 (2007): 514-519.
  49. Bain WE., et al. “The fellow eye in acute closed-angle glaucoma”. British Journal of Ophthalmology 4 (1957): 193-199.
  50. Lowe RF., et al. “Acute angle-closure glaucoma. The second eye: An analysis of 200 cases”. British Journal of Ophthalmology11 (1962): 641-650.

Anuradha Raj and Vinita Kumari. "Angle-Closure Glaucoma: An Insight." EC Ophthalmology 15.11 (2024): 01-11.

ECronicon Journal

Our Services

Quick Links

Information

Creative Commons LicenseOpen Access by ECronicon is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at www.ecronicon.net